| Courtney Donielle Unkefer, NP | |
|
7000 Justin Rd, Lantana, TX 76226-8412 | |
| (940) 584-0365 | |
| Not Available |
| Full Name | Courtney Donielle Unkefer |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 7000 Justin Rd, Lantana, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184110256 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | AP137880 (Texas) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | AP137880 (Texas) | Primary |
| Entity Name | Texas Digestive Disease Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053397331 PECOS PAC ID: 3375531379 Enrollment ID: O20040505001844 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of Phase II clinical trial of the company's investigative immunomodulatory agent, CYT107 (rhIL-7), in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir (ISENTRESS- Merck & Co.) and the CCR5 inhibitor, maraviroc (SELZENTRY- ViiV Healthcare).
The first international Expert Consultation on Paediatric Essential Medicines, jointly held by the World Health Organization (WHO) and the United Nation's Children's Fund (UNICEF), has delivered a plan to boost access to essential medicines for children.
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that current and former users of marijuana are more likely to have prediabetes-the state of poor blood sugar control that can progress to type 2 diabetes-than never users of marijuana. However the researchers, led by Mike Bancks (University of Minnesota School of Public Health, Minneapolis, MN, USA) failed to establish a direct link between marijuana use and type 2 diabetes.
Measuring three biomarkers in a single blood sample may improve physicians' ability to identify patients at high risk of developing chronic kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.
Qualitest Pharmaceuticals today confirmed that it has launched a generic version of Singulair (montelukast sodium) Tablets and Chewable Tablets, following the expiration of the last patent that provides Merck U.S. market exclusivity. Qualitest will begin shipping the product immediately. Montelukast Sodium Tablets are labeled for use in treating symptoms of asthma and allergic rhinitis.
› Verified 6 days ago
| Entity Name | Adjuvant Behavioral Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497485106 PECOS PAC ID: 2860865557 Enrollment ID: O20230503002424 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of Phase II clinical trial of the company's investigative immunomodulatory agent, CYT107 (rhIL-7), in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir (ISENTRESS- Merck & Co.) and the CCR5 inhibitor, maraviroc (SELZENTRY- ViiV Healthcare).
The first international Expert Consultation on Paediatric Essential Medicines, jointly held by the World Health Organization (WHO) and the United Nation's Children's Fund (UNICEF), has delivered a plan to boost access to essential medicines for children.
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that current and former users of marijuana are more likely to have prediabetes-the state of poor blood sugar control that can progress to type 2 diabetes-than never users of marijuana. However the researchers, led by Mike Bancks (University of Minnesota School of Public Health, Minneapolis, MN, USA) failed to establish a direct link between marijuana use and type 2 diabetes.
Measuring three biomarkers in a single blood sample may improve physicians' ability to identify patients at high risk of developing chronic kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.
Qualitest Pharmaceuticals today confirmed that it has launched a generic version of Singulair (montelukast sodium) Tablets and Chewable Tablets, following the expiration of the last patent that provides Merck U.S. market exclusivity. Qualitest will begin shipping the product immediately. Montelukast Sodium Tablets are labeled for use in treating symptoms of asthma and allergic rhinitis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Courtney Donielle Unkefer, NP 7000 Justin Rd, Lantana, TX 76226-8412 Ph: (940) 584-0365 | Courtney Donielle Unkefer, NP 7000 Justin Rd, Lantana, TX 76226-8412 Ph: (940) 584-0365 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of Phase II clinical trial of the company's investigative immunomodulatory agent, CYT107 (rhIL-7), in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir (ISENTRESS- Merck & Co.) and the CCR5 inhibitor, maraviroc (SELZENTRY- ViiV Healthcare).
The first international Expert Consultation on Paediatric Essential Medicines, jointly held by the World Health Organization (WHO) and the United Nation's Children's Fund (UNICEF), has delivered a plan to boost access to essential medicines for children.
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that current and former users of marijuana are more likely to have prediabetes-the state of poor blood sugar control that can progress to type 2 diabetes-than never users of marijuana. However the researchers, led by Mike Bancks (University of Minnesota School of Public Health, Minneapolis, MN, USA) failed to establish a direct link between marijuana use and type 2 diabetes.
Measuring three biomarkers in a single blood sample may improve physicians' ability to identify patients at high risk of developing chronic kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.
Qualitest Pharmaceuticals today confirmed that it has launched a generic version of Singulair (montelukast sodium) Tablets and Chewable Tablets, following the expiration of the last patent that provides Merck U.S. market exclusivity. Qualitest will begin shipping the product immediately. Montelukast Sodium Tablets are labeled for use in treating symptoms of asthma and allergic rhinitis.
› Verified 6 days ago